Drug Profile
Monoclonal antibody MOC31 ETA(252-613) conjugate
Alternative Names: MOC31 ETA252-613Latest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lung cancer
Most Recent Events
- 09 May 1997 New profile
- 09 May 1997 Preclinical development for Lung cancer in Switzerland (Unknown route)